Lucy Ellen DesJardin

Title: Lucy Ellen DesJardin: Innovator in Tuberculosis Detection

Introduction

Lucy Ellen DesJardin is a notable inventor based in Little Rock, Arkansas. She has made significant contributions to the field of medical diagnostics, particularly in the detection of tuberculosis. With a total of 2 patents, her work has advanced the methods used to identify and confirm the presence of this serious disease.

Latest Patents

DesJardin's latest patents focus on the detection of the M. tuberculosis complex via reverse transcriptase SDA. The first patent provides primers for complex-specific detection of alpha-antigen DNA in diagnostic assays performed on clinical specimens. This invention allows for the determination of the viability of complex organisms in both clinical specimens and cultured environments. The second patent similarly addresses the detection of M. tuberculosis complex-specific alpha-antigen DNA, utilizing a reverse transcriptase-mediated amplification system. Both patents describe methods for detecting amplification products using radiolabeled probes through chemiluminescent assays or fluorescence polarization analysis.

Career Highlights

Throughout her career, Lucy Ellen DesJardin has worked with the University of Arkansas, contributing her expertise to various research initiatives. Her innovative approaches have led to advancements in diagnostic techniques, particularly in the realm of infectious diseases.

Collaborations

DesJardin has collaborated with notable colleagues, including Mac Donald Cave and Kathleen D Eisenach. These partnerships have further enriched her research and development efforts in the field of tuberculosis detection.

Conclusion

Lucy Ellen DesJardin's contributions to medical diagnostics, particularly in tuberculosis detection, highlight her role as an influential inventor. Her patents and collaborative efforts continue to impact the field positively.